Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Patent
1987-03-09
1991-04-16
Draper, Garnette D.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
530820, 435 695, 435 6952, 424 851, 424 852, C07K 1300, A61K 3700
Patent
active
050083740
ABSTRACT:
An interleukin-1.alpha. (IL-1.alpha.) derivative having a modified amino acid sequence of IL-1.alpha., a gene coding for said derivative, medicinal composition comprising said derivative as a pharmaceutically effective component and a medicinal use of homogeneous IL-1.alpha..
REFERENCES:
patent: 4568640 (1986-02-01), Rubin
patent: 4762914 (1988-08-01), Aaron et al.
patent: 4770781 (1988-09-01), Schmidt et al.
patent: 4774320 (1988-09-01), Toyliabue et al.
Dinarello, J. Clin. Immunol., vol. 5(5) 1985, pp. 287-297.
Endo et al., Immunobial 172, 1986, pp. 316-322.
Boraschi et al., Eur. J. Immunol., 20, 1990, pp. 317-321.
Friedman et al., Peptides, 1990, ed Rivier et al., pp. 220-222.
Wingfield et al., Protein Engineering, vol. 1(5) 1987, pp. 413-417.
Zurawski et al., Gene 49, 1986, pp. 61-68.
Bachmair et al., Science, 234, 1986, pp. 179-186.
Regenmsitel, TIBS 11, 1986, pp. 36-39.
King, Bio./Technology, vol. 4, 1986, pp. 297-303.
Subramonian, Bio./Technology, vol. 3, 1985, p. 597.
Wells et al., Gene 34, 1985, pp. 315-323.
Journal of Immunology, vol. 122, No. 6, pp. 2112-2118, Togawa et al., Characterization of Lymphocyte-Activating Factor (LAF) Produced by Human Mononuclear Cells: Biochemical Relationship of High and Low Molecular Weight Forms of LAF.
Federation Proceedings, vol. 41, No. 2, pp. 257-262, Lymphokines: their role in lymphocyte response, Oppenheim et al.
Cellular Immunology, vol. 48, pp. 223-229, 1983, Interleukin 1 Production by a Human Acute Monocytic Leukemia Cell Line, Nat. Inst. Dental Res.
Nature, vol. 309, 1984, Human Large Granular Lymphocytes are Potent Producers of Interleukin-1, Scala et al.
Journal of Experimental Medicine, vol. 160, pp. 772-787, Purification and Partial Biochemical Characterization of Normal Human Interleukin-1, John A. Schmidt.
Cellular Immunology, vol. 48, pp. 433-436, 1979, Revised Nomenclature for Antigen-Nonspecific T-Cell Proliferation and Helper Factors.
Reviews of Infectious Diseases, vol. 6, No. 1, pp. 51-95, Interleukin-1, Charles A. Dinarello.
The New England Journal of Medicine, vol. 311, No. 22, 1984, Interleukin-1 and the Pathogenesis of the Acute-Phase Response, Dinarello.
Proc. Natl. Acad. Sci., vol. 81, pp. 7907-7911, 1984, Nucleotide Sequence of Human Monocyte Interleukin-1 Precursor cDNA, Auron et al.
Nature, vol. 315, pp. 641-647, 1985, Cloning, Sequence and Expression of Two Distinct Human Interleukin-1 Complementary DNAs, March et al.
Nucleic Acids Research, vol. 13, No. 16, pp. 5869-5882, 1985, Cloning and Characterization of the cDNAs for Human and Rabbit Interleukin-1 Precursor, Furutani et al.
Nature, vol. 304, pp. 449-451, 1983, The Pyrogenic and Mitogenic Actions of Interleukin-1 are related, Duff et al.
Cellular Immunology, vol. 63, pp. 164-176, The Role of Macrophages in the Acute-Phase Response:SAA Inducer is Closely Related to Lymphocyte Activating Factor and Endogeneous Pyrogen, Sztein et al.
Journal of Experimental Medicine, vol. 150, pp. 2708-2714, 1983, Adherent Cell Function in Murine T-Lymphocyte Antigen Recognition, Rosenwasser, Dinarello, Rosenthal.
The Journal of Immunology, vol. 130, No. 6, pp. 2708-2714, 1983, The Role of Interleukin 1 in Human B Cell Activation: Inhibition of B Cell, etc., Lipsky, Thompson, Rosenwasser & Dinarello.
The Journal of Immunology, vol. 132, No. 3, 1984, Role of Interleukin-1 in Antigen-Specific T Cell Proliferation, Chu et al.
Nature, vol. 314, pp. 266-268, Homogeneous Interferon-Inducing 22K Factor is related to Endogenous Pyrogen and Interleukin-1, Damme, DeLey, Opdenakker, Billiau & De Somer.
Nature, vol. 312, pp. 458-462, 1984, Cloning and Expression of Murine Interleukin-1 cDNA in Escherichia coli, Lomedica et al.
Biochemical and Biophysical Research Communications, vol. 141, pp. 285-291, Recombinant Human Interleukin 1 Alpha and Beta Stimulate Mouse Osteoblast-Activity and Prostaglandin E.sub.2, Sato et al.
Journal of Experimental Medicine, vol. 161, pp. 490-502, 1985, Human Interleukin, Kronheim, March, Erb, Conlon, Mochizuki & Hopp.
Journal of Experimental Medicine, vol. 162, pp. 790-801, 1985, Amino Acid Sequence Analysis of Human Interleukin 1, Cameron et al.
Journal of Experimental Medicine, vol. 164, pp. 237-250, Purification to Homogeneity and Amino Acid Sequence Analysis of Two Anionic Species of Human Interleukin 1, Cameron et al.
The Journal of Immunology, vol. 135, pp. 3962-3968, 1985, Human Interleukin-1 is a Cytocidal Factor for Several Tumor Cell Lines, Onzaki, Matsushima, Aggarwal & Joost.
The Journal of Immunology, vol. 136, No. 7, pp. 2483-2485, Interleukin 1 is a Radioprotector, Neta, Douches & Joost.
The Journal of Immunology, vol. 136, No. 7, 2492-2497, 1986, Recombinant Human Interleukin 1a: Purification and Biological Characterization, Gubler et al.
The Journal of Immunology, vol. 136, No. 9, pp. 3304-3310, 1986, Purification to Homogeneity and NH.sub.2 -Terminal Amino Acid Sequence of a Novel Interleukin 1 Species Derived from a B Cell Line, Rimsky et al.
Immunology Today, vol. 7, No. 2, pp. 45-56, 1986, There is More than One Interleukin 1, Oppenheim, Kovacs, Matsushima & Durum.
Jpn. J. Cancer Res., (Gann) 77, pp. 767-773, 1986, AntiTumor Effect of Recombinant Human Interleukin 1 Alpha Against Murine Syngereic Tumors, Nakamura et al.
Proceedings of Amer. Assoc. for Cancer Research, vol. 26, pp. 269, 1058.
The Physiologic, Metabolic and Immunologic Actions of Interleukin-1, Proceedings, pp. 253-262, Alan R. Liss.
European Journal of Immunology, vol. 14, pp. 898-901, 1986, Induction of Human Interleukin 1mRNA Measured by Collagenase and Prostaglandin E2-Stimulating Activity in Rheumatoid Synovial Cells, Dayer et al.
Bio./Technology, vol. 4, pp. 1078-1082, 1986, Purification and Characterization of Human Interleukin-1 Expressed in Escherichia coli, Kronheim et al.
Clin. Exp. Immunology, vol. 55, pp. 295-302, 1984, Cytokins and the Chronic Inflammation of Rheumatic Disease., Nouri, Panay & Goodman.
Arthritis and Rheumatism, vol. 26, No. 8, 975-983, 1983, Isolation of an Interleukin-1 Like Factor from Human Joint Effusions, Wood, Jhrie, Dinarello & Cohen.
Arthritis and Rheumatism, vol. 28, pp. 853-862, 1985, Release of Interleukin 1 from Human Synovial Tissue in Vitro, Wood, Jhrie and Hammerman.
Immunological Review, vol. 63, pp. 51-72, 1982, Mechanism of T Cell Activation, Palacios et al.
The Journal of Immunological, vol. 136, No. 8, pp. 3098-3102, 1986, Natural and Recombinant Human Interleukin 1-B is Cytotoxic for Human Melanoma Cells, Lachman et al.
J. Clin. Invest., vol. 79, pp. 48-51, 1987, Interleukin 1 Induces Cultured Human Endothelial Cell Production of Granulocyte-Macrophage Colony-Stimulating Factor, Sieff, Tsai and Faller.
6th Internatl. Con. of Immunology, Abstracts, pp. 343-346, 349, 350-354, Theme Nos. 3.31.14; 3.31.22; 3.31.43; 3.31.39; 3.31.40; 3.31.38; and 3.32.23.
Metabolism, vol. 23, Extra Edition "Immunology '86", pp. 97-104, 1986.
Biochemica and Biophysical Research Communications, vol. 143, pp. 345-352, 1987, cDNA Cloning of IL-1a and IL-1B Form mRNA of U937 Cell Line, Nishida et al.
Medical Immunology, vol. 12, No. 6, pp. 753-760, 1986.
Proc. Jap. Soc. Immunol., vol. 16, 167, 173, 1986.
Biochemistry, vol. 58, No. 8, 840, 1986.
Jpn. J. Clin. Immunol., 9(5), 330-332, 1986.
Hirai Yoshikatsu
Hong Yeong-Man
Ishii Kiyoshi
Kaneta Mayumi
Kawai Kazuyoshi
Draper Garnette D.
Otsuka Pharmaceutical Co. Ltd.
LandOfFree
IL-1.alpha. derivatives and drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with IL-1.alpha. derivatives and drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-1.alpha. derivatives and drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-422105